vanA-mediated high level glycopeptide resistance in MRSA

被引：25
作者：
González-Zorn, B [1 ]
Courvalin, P [1 ]
机构：
[1] Inst Pasteur, Unite Agents Antibacteriens, F-75724 Paris 15, France
来源：
LANCET INFECTIOUS DISEASES | 2003年 / 3卷 / 02期
关键词：
D O I：
10.1016/S1473-3099(03)00510-3
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：67 / 68
页数：2
相关论文
共 14 条
  • [1] [Anonymous], 2002, MMWR MORB MORTAL WKL, V51, P565
  • [2] [Anonymous], MMWR MORB MORTAL WKL
  • [3] Glycopeptide resistance in enterococci
    Arthur, M
    Reynolds, P
    Courvalin, P
    [J]. TRENDS IN MICROBIOLOGY, 1996, 4 (10) : 401 - 407
  • [4] *CDC, 2002, MMWR-MORBID MORTAL W, V51, P902
  • [5] Community-acquired methicillin-resistant Staphylococcus aureus infections in France:: Emergence of a single clone that produces Panton-Valentine leukocidin
    Dufour, P
    Gillet, Y
    Bes, M
    Lina, G
    Vandenesch, F
    Floret, D
    Etienne, J
    Richet, H
    [J]. CLINICAL INFECTIOUS DISEASES, 2002, 35 (07) : 819 - 824
  • [6] *EARSS, 2001, ANN REP EARSS 2001
  • [7] Low dosage and long treatment duration of β-lactam -: Risk factors for carriage of penicillin-resistant Streptococcus pneumoniae
    Guillemot, D
    Carbon, C
    Balkau, B
    Geslin, P
    Lecoeur, H
    Vauzelle-Kervroëdan, F
    Bouvenot, G
    Eschwége, E
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 279 (05): : 365 - 370
  • [8] Hiramatsu K, 2001, Lancet Infect Dis, V1, P147, DOI 10.1016/S1473-3099(01)00091-3
  • [9] Glycopeptide-resistant Staphylococcus aureus
    Johnson, AP
    Woodford, N
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2002, 50 (05) : 621 - 623
  • [10] PLASMID-MEDIATED RESISTANCE TO VANCOMYCIN AND TEICOPLANIN IN ENTEROCOCCUS-FAECIUM
    LECLERCQ, R
    DERLOT, E
    DUVAL, J
    COURVALIN, P
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1988, 319 (03) : 157 - 161
12